Bevacizumab plus temsirolimus as second-line treatment for advanced hepatocellular carcinoma (HCC).
Leonidas Chelis
No relevant relationships to disclose
Savas Deftereos
No relevant relationships to disclose
Nikolaos Xenidis
No relevant relationships to disclose
Kiriakos Amarantidis
No relevant relationships to disclose
Eleni Kyrillos Hamalidou
No relevant relationships to disclose
Prokopios Dimopoulos
No relevant relationships to disclose
Prodromos Michailidis
No relevant relationships to disclose
Evagelos Christakidis
No relevant relationships to disclose
Kostantinos Mimidis
No relevant relationships to disclose
Dimitra Pitsiava
No relevant relationships to disclose
Anastasios Karayiannakis
No relevant relationships to disclose
Stylianos Kakolyris
No relevant relationships to disclose